2-(4-morpholinyl)-8-phenyl-4h-1-benzopyran-4-one has been researched along with Opsoclonus-Myoclonus Syndrome in 1 studies
2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one: specific inhibitor of phosphatidylinositol 3-kinase; structure in first source
Opsoclonus-Myoclonus Syndrome: A neurological condition that is characterized by uncontrolled rapid irregular movements of the eye (OPSOCLONUS) and the muscle (MYOCLONUS) causing unsteady, trembling gait. It is also known as dancing eyes-dancing feet syndrome and is often associated with neoplasms, viral infections, or autoimmune disorders involving the nervous system.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ding, X | 1 |
Han, W | 1 |
Wang, J | 1 |
Yang, W | 1 |
Chang, XF | 1 |
Zhu, ZY | 1 |
Qin, H | 1 |
Zhang, JZ | 1 |
Wang, X | 1 |
Wang, HM | 1 |
1 other study available for 2-(4-morpholinyl)-8-phenyl-4h-1-benzopyran-4-one and Opsoclonus-Myoclonus Syndrome
Article | Year |
---|---|
IGF-1 alleviates serum IgG-induced neuronal cytolysis through PI3K signaling in children with opsoclonus-myoclonus syndrome and neuroblastoma.
Topics: Animals; Cells, Cultured; Child, Preschool; Chromones; Female; Humans; Immunoglobulin G; Insulin-Lik | 2019 |